BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25847223)

  • 21. JAK/STAT signaling in rheumatoid arthritis leukocytes is uncoupled from serum cytokines in a subset of patients.
    Dreo B; Muralikrishnan AS; Husic R; Lackner A; Brügmann T; Haudum P; Bosch P; Thiel J; Fessler J; Stradner M
    Clin Immunol; 2024 Jul; 264():110238. PubMed ID: 38729230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD4+T-bet+, CD4+pSTAT3+ and CD8+T-bet+ T cells accumulate in peripheral blood during NZB treatment.
    Frisullo G; Iorio R; Plantone D; Marti A; Nociti V; Patanella AK; Batocchi AP
    Mult Scler; 2011 May; 17(5):556-66. PubMed ID: 21177324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preferential and persistent activation of the STAT1 pathway in rheumatoid synovial fluid cells.
    Yokota A; Narazaki M; Shima Y; Murata N; Tanaka T; Suemura M; Yoshizaki K; Fujiwara H; Tsuyuguchi I; Kishimoto T
    J Rheumatol; 2001 Sep; 28(9):1952-9. PubMed ID: 11550959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p53 controls autoimmune arthritis via STAT-mediated regulation of the Th17 cell/Treg cell balance in mice.
    Park JS; Lim MA; Cho ML; Ryu JG; Moon YM; Jhun JY; Byun JK; Kim EK; Hwang SY; Ju JH; Kwok SK; Kim HY
    Arthritis Rheum; 2013 Apr; 65(4):949-59. PubMed ID: 23280308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Competitive binding of STATs to receptor phospho-Tyr motifs accounts for altered cytokine responses.
    Wilmes S; Jeffrey PA; Martinez-Fabregas J; Hafer M; Fyfe PK; Pohler E; Gaggero S; López-García M; Lythe G; Taylor C; Guerrier T; Launay D; Mitra S; Piehler J; Molina-París C; Moraga I
    Elife; 2021 Apr; 10():. PubMed ID: 33871355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A CD4 T cell gene signature for early rheumatoid arthritis implicates interleukin 6-mediated STAT3 signalling, particularly in anti-citrullinated peptide antibody-negative disease.
    Pratt AG; Swan DC; Richardson S; Wilson G; Hilkens CM; Young DA; Isaacs JD
    Ann Rheum Dis; 2012 Aug; 71(8):1374-81. PubMed ID: 22532634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-22+ CD4+ T cells in patients with rheumatoid arthritis.
    Zhao L; Jiang Z; Jiang Y; Ma N; Zhang Y; Feng L; Wang K
    Int J Rheum Dis; 2013 Oct; 16(5):518-26. PubMed ID: 24164838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamic balance of pSTAT1 and pSTAT3 in C57BL/6 mice infected with lethal or nonlethal Plasmodium yoelii.
    Shi X; Qin L; Liu G; Zhao S; Peng N; Chen X
    Cell Mol Immunol; 2008 Oct; 5(5):341-8. PubMed ID: 18954557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood Leukocyte Signaling Pathways as Predictors of Severity of Acute Pancreatitis.
    Turunen A; Kuuliala A; Mustonen H; Puolakkainen P; Kylänpää L; Kuuliala K
    Pancreas; 2021 May-Jun 01; 50(5):710-718. PubMed ID: 34016897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene associated with retinoid-interferon-induced mortality 19 attenuates murine autoimmune arthritis by regulation of th17 and treg cells.
    Moon YM; Lee J; Lee SY; Her YM; Ryu JG; Kim EK; Son HJ; Kwok SK; Ju JH; Yang CW; Park SH; Kim HY; Cho ML
    Arthritis Rheumatol; 2014 Mar; 66(3):569-78. PubMed ID: 24574216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of pre-B cell colony-enhancing factor by STAT-3-dependent interleukin-6 trans-signaling: implications in the pathogenesis of rheumatoid arthritis.
    Nowell MA; Richards PJ; Fielding CA; Ognjanovic S; Topley N; Williams AS; Bryant-Greenwood G; Jones SA
    Arthritis Rheum; 2006 Jul; 54(7):2084-95. PubMed ID: 16802343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of IL-6 and IL-6 blockade on neutrophil function in vitro and in vivo.
    Wright HL; Cross AL; Edwards SW; Moots RJ
    Rheumatology (Oxford); 2014 Jul; 53(7):1321-31. PubMed ID: 24609058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Activity of JAK/STAT and NF-κB in Patients with Rheumatoid Arthritis.
    Świerkot J; Nowak B; Czarny A; Zaczyńska E; Sokolik R; Madej M; Korman L; Sebastian A; Wojtala P; Lubiński Ł; Wiland P
    Adv Clin Exp Med; 2016; 25(4):709-17. PubMed ID: 27629845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reciprocal roles of STAT3 and STAT5 in nasal polyposis.
    Wang XQ; Hu GH; Kou W; Shen Y; Kang HY; Hong SL
    Am J Otolaryngol; 2012; 33(6):741-52. PubMed ID: 22959364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Humanised antihuman IL-6R antibody with interferon inhibits renal cell carcinoma cell growth in vitro and in vivo through suppressed SOCS3 expression.
    Oguro T; Ishibashi K; Sugino T; Hashimoto K; Tomita S; Takahashi N; Yanagida T; Haga N; Aikawa K; Suzutani T; Yamaguchi O; Kojima Y
    Eur J Cancer; 2013 May; 49(7):1715-24. PubMed ID: 23274199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crucial role of the interleukin-6/interleukin-17 cytokine axis in the induction of arthritis by glucose-6-phosphate isomerase.
    Iwanami K; Matsumoto I; Tanaka-Watanabe Y; Inoue A; Mihara M; Ohsugi Y; Mamura M; Goto D; Ito S; Tsutsumi A; Kishimoto T; Sumida T
    Arthritis Rheum; 2008 Mar; 58(3):754-63. PubMed ID: 18311788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deficient phosphorylation of Stat1 in leukocytes identifies neutralizing antibodies in multiple sclerosis patients treated with interferon-beta.
    Gavasso S; Mosleth EF; Marøy T; Jørgensen K; Nakkestad HL; Gjertsen BT; Myhr KM; Vedeler C
    PLoS One; 2014; 9(2):e88632. PubMed ID: 24586361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum interleukin 6 before and after therapy with tocilizumab is a principal biomarker in patients with rheumatoid arthritis.
    Shimamoto K; Ito T; Ozaki Y; Amuro H; Tanaka A; Nishizawa T; Son Y; Inaba M; Nomura S
    J Rheumatol; 2013 Jul; 40(7):1074-81. PubMed ID: 23637318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-interleukin-6 signalling therapy rebalances the disrupted cytokine production of B cells from patients with active rheumatoid arthritis.
    Fleischer S; Ries S; Shen P; Lheritier A; Cazals F; Burmester GR; Dörner T; Fillatreau S
    Eur J Immunol; 2018 Jan; 48(1):194-203. PubMed ID: 28850672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased expression of miR-146a and miR-155 contributes to an abnormal Treg phenotype in patients with rheumatoid arthritis.
    Zhou Q; Haupt S; Kreuzer JT; Hammitzsch A; Proft F; Neumann C; Leipe J; Witt M; Schulze-Koops H; Skapenko A
    Ann Rheum Dis; 2015 Jun; 74(6):1265-74. PubMed ID: 24562503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.